๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): Review and report of thirty novel mutations

โœ Scribed by Stephen I. Goodman; Donna E. Stein; Sudha Schlesinger; Ernst Christensen; Marianne Schwartz; Cheryl R. Greenberg; Orly N. Elpeleg


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
245 KB
Volume
12
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Glutaric acidemia type I (GA1

) is caused by mutations in the gene encoding the enzyme glutaryl-CoA dehydrogenase (GCD). Sixty-three pathogenic mutations identified by several laboratories are presented, 30 of them for the first time, together with data on expression in Escherichia coli and relationship to the clinical and biochemical phenotype. In brief, many GCD mutations cause GA1, but none is common. There is little if any relationship between genotype and clinical phenotype, but some mutations, even when heterozygous, seem especially common in patients with normal or only minimally elevated urine glutaric acid.


๐Ÿ“œ SIMILAR VOLUMES


Novel mutations of the glutaryl-CoA dehy
โœ lkeda, Hiroyuki; Kimura, Toshiyuki; Ikegami, Tohru; Kato, Mitsuhiro; Matsunaga, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 9 KB ๐Ÿ‘ 2 views

We identified three different point mutations in the glutaryl-CoA dehydrogenase (GCDH) gene in two unrelated Japanese patients with glutaric aciduria type I (GA-I). One patient was a homozygote for Arg355His and the other a compound heterozygote for Ser305Leu and Met339Val. Arg355His and Met339Val a

Recurrent and novel mutations of GCDH ge
โœ Nelson L.S. Tang; Joannie Hui; L.K. Law; Y.Y. Lam; K.Y. Chan; W.L. Yeung; Albert ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 35 KB

Glutaric acidemia type I is caused by mutations of the glutaryl-CoA dehydrogenase (GCDH) gene resulting in loss of GCDH enzyme activity. Patients present with progressive dystonia and lesions in basal ganglia. Dietary treatment, when instituted from the early neonatal period, markedly reduces dyston